A director at Wolters Kluwers bought 619 shares at 155.540USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India Louvain-La-Neuve, Belgium, March 04, 2025 – (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a term sheet with Apollo Hospitals Enterprise Limited (AHEL) for the supply of one Proteus®ONE1 compact proton therapy solution plus a second one in option. Apollo will therefore expand access to proton therapy in India. The te...
IBA et Apollo Hospitals signent une lettre d’intention pour l'installation d’un système Proteus®ONE et d’un second en option en Inde Louvain-la-Neuve, Belgique, le 4 mars 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et le premier fournisseur de solutions de protonthérapie pour le traitement du cancer, annonce aujourd'hui avoir signé une lettre d’intention avec Apollo Hospitals Enterprise Limited (AHEL) pour la fourniture d’une solution de protonthérapie compacte Proteus®ONE1 et d’une seconde en option. Apollo va ainsi é...
Azelis proved its resilience over the past years with organic revenue CAGR of 6.6% (2020-2024) combined with robust margin expansions. Therefore, Azelis could be a safe haven in volatile times, supported by their strong geographical and end-market diversification. Nevertheless, we believe that CSS's organic revenue growth expectations are too optimistic. On the other hand, the upside from acquisitions is undervalued. We provide a detailed overview on the acquisitional revenue growth, which we lo...
JDE Peet’s starts EUR 250 million share buyback programme PRESS RELEASEAmsterdam, March 3, 2025JDE Peet’s (EURONEXT: JDEP), the world’s leading pure-play coffee and tea company by revenue, today announced the start of its share buyback programme to return up to EUR 250 million to shareholders in 2025, as . The programme will start on March 3, 2025 and the maximum duration of the programme is up to the end of 2025, barring unforeseen circumstances. The main purpose of the programme is to reduce the capital of JDE Peet’s, by cancelling virtually all the ordinary shares acquired through the p...
We reiterate our HOLD as we remain concerned by: (1) the group's high exposure to emerging markets, with >50% of group Adj. EBITDA generated by the ‘Turkey & Emerging Markets' division, in a highly cyclical industry; and (2) the significant impact raw material prices can have on profitability. We see downside risk to the Turkey & EM division margins after two abnormally high years driven by continued weakening of the Turkish lira, in our view. This materially boosted profitability in emerging ma...
We updated our model and maintain our positive stance (Buy, € 175 Target Price) after a very good set of FY24 results. We welcome DEME's end FY24 orderbook reached a new record (€ 8.2bn), even with the high conversion of backlog into revenue. The 8% y/y growth was mainly driven by continued increases in Offshore Energy orders (+13% y/y to € 4.3bn). While Dredging&Infra (€ 3.6bn) experienced a more moderate but still healthy rise, Environmental (€ 352m) maintained a stable orderbook. With effec...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.